S'abonner

Changes in and predictors of pain and mortality in patients with chronic obstructive pulmonary disease - 09/09/20

Doi : 10.1016/j.rmed.2020.106116 
Signe B. Bentsen a, , Are M. Holm b, c , Vivi L. Christensen d , Anne H. Henriksen e, f , Milada Cvancarova Småstuen g, h , Tone Rustøen g, i
a Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway 
b Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Pb 4950, Nydalen, 0424, Oslo, Norway 
c Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway, Pb 1171, Blindern, 0318, Oslo, Norway 
d Lovisenberg Diaconal University College, Lovisenberggt 15, 0456, Oslo, Norway 
e Department of Thoracic and Occupational Medicine, Trondheim University Hospital, Trondheim, 7006, Norway 
f Department of Circulation and Medical Imaging, St Olav's University Hospital, Olav Kyrres Gate 17, 7030, Trondheim, Norway 
g Department of Research and Development, Division of Emergencies and Critical Care, Oslo University Hospital, Ullevaal, Pb 4956, Nydalen, Oslo, Norway 
h Department of Public Health, Faculty of Nursing Science, Oslo Metropolitan University, Pb 4 St.Olavs Plass, Oslo, Norway 
i Institute of Health and Society, Department of Nursing Science, University of Oslo, Nedre Ullevaal 9, Stjerneblokka, 0850, Oslo, Norway 

Corresponding author. Western Norway University of Applied Sciences, Department of Health and Caring Sciences, Norway, Pb 7030, 5020, Bergen, Norway.Western Norway University of Applied SciencesDepartment of Health and Caring SciencesPb 7030Bergen5020Norway

Abstract

This longitudinal study of patients with chronic obstructive pulmonary disease (COPD) aimed to investigate changes in pain characteristics (i.e., occurrence, intensity, and interference) and covariates associated with pain from study enrollment to 12 months, and to investigate if the different pain characteristics were associated with 5-year mortality. In total, 267 patients with COPD completed questionnaires five times over 1 year. The mean age of the patients was 63 years (standard deviation: 9.0), 53% were women, and 46% had very severe COPD. Median number of comorbidities was 2.0 (range: 0–11) and 47% of patients reported back/neck pain. Mixed models and Cox regression models were used for analyses. In total, 60% of the patients reported pain at baseline, and 61% at 12 months. The mixed model analyses revealed that those with better forced expiratory volume in 1 s (% predicted), more comorbidities, only primary school education, and more respiratory symptoms reported significantly higher average pain intensity. Moreover, those with more comorbidities, more respiratory symptoms, and more depression reported higher pain interference with function. At the 5-year follow-up, 64 patients (24%) were deceased, and the cumulative 5-year mortality rate was 22% (95% confidence interval [19–25]). Older age, lower forced expiratory volume in 1 s (% predicted), and higher pain interference at enrollment were all independently and significantly associated with higher 5-year mortality. Our findings show that many patients with COPD have persistent pain, and awareness regarding comorbidities and how pain interferes with their lives is needed.

Le texte complet de cet article est disponible en PDF.

Highlights

Pain is generally not among the listed symptoms in patients with COPD.
No studies have examined changes of a broader spectrum of pain over time in COPD.
No studies have examined the association between pain and mortality in COPD patents.
Pain is a significant and long-lasting burden for COPD patients.
We hope that our study may increase the awareness of pain in patients with COPD.

Le texte complet de cet article est disponible en PDF.

Keywords : Chronic obstructive pulmonary disease, Longitudinal study, Mortality, Pain, Symptoms


Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 171

Article 106116- septembre 2020 Retour au numéro
Article précédent Article précédent
  • Sex differences between women and men with COPD: A new analysis of the 3CIA study
  • Tamara Alonso Perez, Elena García Castillo, Julio Ancochea, María Teresa Pastor Sanz, Pere Almagro, Pablo Martínez-Camblor, Marc Miravitlles, Mónica Rodríguez-Carballeira, Annie Navarro, Bernd Lamprecht, Ana S. Ramírez-García Luna, Bernhard Kaiser, Inmaculada Alfageme, Ciro Casanova, Cristóbal Esteban, Juan J. Soler-Cataluña, Juan P. De-Torres, Bartolomé R. Celli, Jose M. Marin, Jose L. Lopez-Campos, Gerben Ter Riet, Patricia Sobradillo, Peter Lange, Judith Garcia-Aymerich, Josep M. Anto, Alice M. Turner, MeiLan K. Han, Arnulf Langhammer, Alice Sternberg, Linda Leivseth, Per Bakke, Ane Johannessen, Toru Oga, Borja Cosío, Andres Echazarreta, Nicolas Roche, Pierre-Régis Burgel, Don D. Sin, Milo A. Puhan, Joan B. Soriano
| Article suivant Article suivant
  • Predictive anatomical factors of lung aerosol deposition in obese individuals. Would modified mallampati score be relevant? Clinical trial
  • Taciano Rocha, Catarina Rattes, Caio Morais, Renata Souza, Nadja Rolim, Simone Brandão, James B. Fink, Armèle Dornelas de Andrade

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.